The Breast Examination Center of Harlem’s Harold Freeman pioneered the system of personal care and service provided by patient navigators to prevent sick people and poor people from falling through the cracks in healthcare delivery.
Hematologist-oncologist Mark Heaney discusses recent studies that suggest multivitamins and many other dietary supplements often don’t have health benefits — and in some cases may even cause harm.
Seventeen-year-old Ella Landesberg has been chronicling the ups and downs of her experience battling acute lymphoblastic leukemia on her blog. Pediatric hematologist-oncologist Peter Steinherz explains the disease.
Epidemiologist Colin Begg discusses a new analysis published in the Archives of Internal Medicine that offers a stark reality check about the value of mammography screening.
As part of a national study on the effectiveness of copper as an antimicrobial surface, Memorial Sloan-Kettering was one of several U.S. hospitals to temporarily install copper-coated equipment surfaces in some intensive care units. Investigator and infectious disease specialist Kent Sepkowitz is quoted.
Medical oncologist Maura Dickler discusses new research that found that the breast cancer drug letrozole, marketed as Femara, may be more effective than tamoxifen at preventing the return of breast cancer and improving survival among older women with hormone-sensitive breast cancers.
Medical oncologist Elizabeth Comen discusses new research that shows that adding radiation therapy to breast-conserving surgery halves the chance that cancer will come back and reduces the risk of dying from breast cancer, when compared to the breast-conserving surgery alone.
Watch medical oncologist Larry Norton speaking about the latest in breast cancer research on ABC's The View. Norton is Memorial Sloan-Kettering's Deputy Physician-in-Chief for Breast Cancer Programs as well as the Medical Director of the Evelyn H. Lauder Breast Center.
The neuroblastoma team at Memorial Sloan-Kettering was honored with a $125,000 grant from Arms Wide Open Childhood Cancer Foundation. Awards of Excellence went to pediatric surgeon Michael La Quaglia and nurse practitioner Ester Dantis.
Surgical oncologist Monica Morrow discusses the growing trend among young women who are choosing aggressive surgery called contralateral prophylactic mastectomy.
Eyewitness News reporter and cancer survivor Stacey Sager discusses genetic testing for the mutation that causes breast and ovarian cancer. Medical oncologist and geneticist Kenneth Offit, gynecologic oncologist Carol Aghajanian, and gynecologic surgeon Richard Barakat were all interviewed for the special.
Memorial Sloan-Kettering epidemiologist Andrew Vickers discusses new research that found that vitamin E supplements may increase the risk of prostate cancer.
Memorial Sloan-Kettering’s Brooklyn Infusion Center is profiled in this piece. "Patients own this facility and design their own experience," said Wendy Perchick, MSKCC's Chief of Strategic Planning and Innovation, adding: "The best testament to the success of this new model for cancer treatment? A patient told me that he felt the healing intensified here because he was so relaxed."
Memorial Sloan-Kettering is one of only two hospitals to offer advanced medical fellowships to physicians who want to specialize in cancer rehabilitation. Chief of MSKCC’s Rehabilitation Medicine Service Michael Stubblefield is mentioned.
Memorial Sloan-Kettering medical oncologist Nicole Lamanna discusses new research that shows clear benefits of the combination of Campath and Fludara for relapsed refractory cases of Chronic Lymphocytic Leukemia (CLL).
MSKCC's proposal to build a $142 million outpatient cancer center in Westchester County was approved by state officials. Executive Director of Memorial Sloan-Kettering's Regional Care Network Victor Ribaudo is quoted.
Despite having the same name, the diseases that killed Steve Jobs and 2011 Nobel Prize winner Ralph Steinman are two different kinds of cancer. Medical oncologist Leonard Saltz explains.
